Baseline central macular thickness predicts the need for retreatment with intravitreal triamcinolone plus laser photocoagulation for diabetic macular edema | Zendy

Roderick O’Day | Zendy; Barthelmes | Zendy; Zhu | Zendy; Tien Yin Wong | Zendy; McAllister | Zendy; Jennifer Arnold | Zendy; Mark C. Gillies | Zendy

Open Access

Baseline central macular thickness predicts the need for retreatment with intravitreal triamcinolone plus laser photocoagulation for diabetic macular edema

Author(s) -

Roderick O’Day,

Barthelmes,

Zhu,

Tien Yin Wong,

McAllister,

Jennifer Arnold,

Mark C. Gillies

Publication year - 2013

Publication title -

clinical ophthalmology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.025

H-Index - 56

eISSN - 1177-5483

pISSN - 1177-5467

DOI - 10.2147/opth.s47424

Subject(s) - medicine , ophthalmology , diabetic macular edema , macular edema , triamcinolone acetonide , diabetic retinopathy , intraocular pressure , optometry , visual acuity , interquartile range , diabetes mellitus , surgery , endocrinology

To identify baseline characteristics that predict the number of treatments with intravitreal triamcinolone acetonide (IVTA) plus laser photocoagulation needed to treat diabetic macular edema over a 2-year period.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research